Evaluation of a novel nutritional supplement to support eye health
CLOSE
MENU

Evaluation of a novel nutritional supplement to support eye health


Content provided by Bausch + Lomb Global Medical and Scientific Affairs.

Evaluation of a novel nutritional supplement to support eye health


Content provided by Bausch + Lomb Global Medical and Scientific Affairs.

Summary

PURPOSE: Ocular surgery procedures can exacerbate or induce dry eye. Nutritional supplementation can support eye health and help mitigate pre- and post-surgical issues. NutriTears (NT) is an oral supplement containing lutein & zeaxanthin isomers, curcuminoids, and vitamin D3. This study evaluated the efficacy and safety of NT in participants with dry eye.

METHODS: This randomized, double-blind, placebo (PBO)-controlled study was conducted at 4 US study centers. Participants were required to meet the following criteria in ≥1 eye: (1) Schirmer's test without anesthesia ≤10 mm; and (2) Ocular Surface Disease Index (OSDI) test symptoms 12–40. Participants were also required to have in ≥1 eye: (1) Tear film break-up time ≤10 seconds; (2) Tear osmolarity ≥316 mOsm/L; or (3) Fluorescein corneal staining ≥1 and <3. The study involved 5 visits with follow-up out to Day 56 (±3 days). Participants consumed one soft gel capsule per day with breakfast.

RESULTS: Of 155 randomized participants, 116 (NT=57; PBO=59) completed the study. A significant group-by-time interaction was detected for OSDI Total Score as well as the subscale domains for Symptoms, Vision and Environmental (p<0.001 for all). Values for the OSDI Total Score, Symptoms and Vision domains were significantly lower in the NT group vs PBO at Days 14 (p<0.05), 28 (p<0.05) and 56 (p<0.001). Schirmer's test (mean [standard deviation] of both eyes) was 7.3 (±3.29) mm for NT and 7.61 (±2.37) mm for PBO at baseline; 11.6 (±3.89) mm for NT and 8.22 (±2.44) mm for PBO at end of treatment (p<0.001). One subject from each group reported ≥1 adverse event; no serious adverse events were reported.

CONCLUSION: The administration of one NT soft gel capsule per day for 8 weeks was effective at improving dry eye symptoms across OSDI domains and tear volume as measured by Schirmer's test compared with PBO. Given the potential impact of pre- and post-surgery dry eye symptoms on outcomes, NT may be a viable surgical adjunct.

For More Information:

Get Support

Contact Us

Contact a
Representative

Find My Local Rep link-out icon

Submit a
Medical Inquiry

Complete the Form